Background Individuals with allergies have a heightened Th2 (T helper 2) immunity, which may provide advantages in controlling tumor growth. Inverse associations have been reported among individuals with allergies and risk of brain and pancreatic cancers. Methods We examined the relationship between allergies and risk of head and neck squamous cell carcinoma (HNSCC) in a population-based case-control study with 1,014 cases and 1,193 frequency-matched controls.
Introduction
A growing number of epidemiological studies support the hypothesis that individuals with allergies have a lower risk of cancer. The most consistent inverse associations have been observed for brain tumors [1] , pancreatic cancer [2] , and childhood leukemia [3] ; results for other cancer sites are less consistent or data are sparse [4, 5] . Two case-control studies observed greater than 50 % reductions in cancer risk of the oral cavity and pharynx, and of the larynx, among individuals who reported a history of allergies [6] , or among men who reported a history of hay fever or other allergies [7] . Furthermore, lower risk of cancer of the lip and pharynx [8] , and of the larynx [9] , was observed in cohorts of asthmatic patients compared with the national population.
Individuals with allergies may have an enhanced immune-surveillance through heightened Th2 immunity, which may assist in tumor cell recognition and destruction through antibody-dependent cellular cytotoxicity [10] . The exact mechanisms, however, are not clear and, the role of immunoglobulin E (IgE), as recently studied in relation to risk of glioma [11, 12] , is complex.
The importance of human papillomavirus type 16 (HPV16) in head and neck cancer has been clarified in the past decade and highlights the critical role of the immune system in relation to risk. Over 52,000 individuals are diagnosed annually with head and neck cancer in the US [13] . While approximately 75 % of these cancers could be prevented by eliminating exposure to smoking and alcohol, understanding other risk factors could provide new clues to mechanisms which may lead to improved treatment options.
Using self-reported history of allergy in a large US population-based case control study, we sought to further clarify the role of allergies in head and neck cancer. Unlike previous studies, we were able to adjust for HPV16 status and reported allergy prevalence similar to those observed in the general population. Additionally, we assessed whether the association is modified by HPV16 status, tumor site, or smoking.
Materials and methods

Study population
Incident cases of head and neck squamous cell carcinoma (HNSCC) were identified and recruited from head and neck clinics and departments of otolaryngology or radiation oncology at 9 medical facilities in the Greater Boston Metropolitan Area. Our method identified 99 % of the cases in the catchment area (confirmed using state cancer registry). Patients with a confirmed incident diagnosis of HNSCC were included if they were residents in the study area and 18 years or older. Recurrent cases and incident cases diagnosed more than 6 months prior to contact were excluded. HNSCC cases consist of those with a diagnosis code of 141-146, 148, 149, or 161 based on the International Classification of Disease, Ninth Revision (ICD-9). Controls were randomly selected from the same population and frequency-matched to cases by sex, age (±3 years), and town of residence using the Massachusetts town lists. The study population for this analysis includes data collected from two periods of recruitment from the same population; the first period was between December 1999 and December 2003 (Phase I) and the second was between October 2006 and June 2011 (Phase II). Participation rates for cases and controls were 78 and 47 %, respectively. A total of 1,056 cases and 1,252 controls were available for this analysis after combining both phases of the study.
All cases and controls enrolled in the study provided written informed consent as approved by the Institutional Review Boards of the participating institutions.
Exposure data
Cases and controls responded to a self-administered questionnaire to collect data on demographic characteristics, medical history, family history of cancer, detailed smoking and drinking habits, occupational history, and residential history. Frequency of alcoholic beverage consumption measured in drinks (where 1 drink = 5 oz wine, 12 oz beer, 1.5 oz liquor) was combined to provide a total alcohol variable. Questions on ever history of allergies and asthma were included in the medical history section. Subjects who responded ever having had allergies were asked to write-in what type of allergies they had (all but six subjects with allergies completed this section). Questionnaires were provided to cases during their initial clinic visit and were mailed to controls and were returned and reviewed by study personnel during the second visit for cases and first in-person visit for controls. Visits were typically conducted at home or at the workplace (depending on their preference), and controls received $75 as compensation for their time.
Blood specimens were collected from 81 % of cases and 80 % of controls to measure human papillomavirus type 16 (HPV-16) seropositivity (data only available for Phase I; 414 cases and 529 controls with HPV and questionnaire data). Serum from venous blood was separated within 12-24 h of blood drawing and stored at -80°C. To detect antibodies against HPV16 type L1, E6 and E7 proteins, a glutathione S-transferase capture enzyme-linked immunosorbent assay was used in combination with fluorescent bead technology [14] [15] [16] [17] [18] .
Statistical analysis
After excluding 101 participants with missing data on allergies or asthma, a total of 1,014 cases and 1,193 controls were available for this analysis. Case and control differences across baseline characteristics were assessed using t test for categorical variables and ANOVA for continuous variables. Odds ratios (OR) and 95 % confidence intervals (CIs) were estimated for history of allergies or asthma compared to no history of these conditions using unconditional logistic regression and controlling for known risk factors, including age, sex, race (white or other), smoking (pack-years as a continuous variable), smoking status (ever/never), average alcohol drinks per week (continuous), education (low/high school graduate or more), and study Phase (I/II). We applied multiple imputation methods using age and sex to assign values to missing values for alcohol (7 missing), race (5 missing), and education (56 missing); using multiple imputation results in less biased findings when dealing with missing covariate data [19] . Additional control for body mass index (BMI) or income (below/above $50 K per year), or including an interaction term for alcohol and smoking, did not change the observed associations with allergies or asthma and was left out of the final model. We conducted analyses to examine potential confounding and effect modification by HPV16 status on Phase I participants (as HPV16 status not available for Phase II participants).
In addition, we examined the association between allergies and HNSCC risk by tumor site (oral cavity, oropharynx, larynx) assigned according to the American Joint Committee on Cancer (AJCC) classification guidelines [20] . Oral cavity tumors corresponded to ICD-9 codes 143, 144, 145, and, if located at the anterior of the tongue, 141; pharyngeal tumors corresponded to ICD-9 codes 146, 148, 149, and, if at the base of the tongue, 141; and laryngeal tumors corresponded to ICD-9 code 161. Potential modification by sex, smoking, alcohol, and education was examined in stratified analyses, and tests for interaction were conducted using cross-product terms in the logistic regression models.
All analyses were conducted in R (version 2.14) and all tests were two-sided. Multiple imputations were carried out using the R package mi [21] .
Results
The distributions of known risk factors of HNSCC are shown in Table 1 by case-control study. As expected, smoking, alcohol consumption, and HPV16 seropositivity were higher among cases than controls. Controls were more educated than cases. The mean age was 60 years; approximately, two-thirds of subjects were males and most subjects were white. The prevalence of self-reported history of allergy and asthma among controls was 40 % (473/1,193) and 10 % (121/1,193), respectively. We observed a statistically significant inverse association between allergies and risk of HNSCC in this study population (OR = 0.81, 95 % CI = 0.67-0.98, p = 0.02; Table 2 ). The association with history of asthma and risk of HNSCC was weaker and not statistically significant, but in the same direction (OR = 0.89, 95 % CI = 0.66-1.22, p = 0.47; Table 2 ). In addition, we examined associations with different types of allergies, but observed no significant difference by type (e.g., compared to no allergies: OR for food allergies = 0.71, 95 % CI = 0.48-1.04, and OR for non-food allergies = 0.84, 95 % CI = 0.69-1.03).
Inverse associations were observed for history of allergy and asthma with oropharyngeal and laryngeal cancers; no relations were apparent for oral cavity cancers ( Table 2) . Comparing a history of allergy and/or asthma with those who had neither, the association with cancer risk was similar (OR = 0.80, 95 % CI = 0.67-0.96). When comparing history of asthma and allergy with no allergies, the association was slightly stronger, but not statistically significant (OR = 0.70, 95 % CI = 0.47-1.02). The association between allergy and HNSCC was similar for males (OR = 0.82, 95 % CI = 0.66-1.03) and females (OR = 0.76, 95 % CI = 0.54-1.07), and for smoking status (never smokers: OR = 0.75, 95 % CI = 0.54-1.04; former smokers: OR = 0.80, 95 % CI = 0.62-1.02) or alcohol (less than 7 drinks per week: OR = 0.78, 95 % CI = 0.60-1.01; greater than 25 drinks per week: OR = 0.59, 95 % CI = 0.37-0.95). While the associations with allergy and asthma were slightly stronger among individuals who had less education, there were fewer participants in those strata (127 cases, 84 controls), and tests for interaction were not statistically significant.
We examined whether HPV16 serostatus was confounding or modifying the association with allergies using Phase I data (HPV16 status was not available on Phase II (Table 3) . Similarly, there were no interactions between HPV16 serostatus and allergies for oral or pharyngeal cancer.
Discussion
In this large US case-control study, we observed inverse associations for history of allergy and asthma and risk of head and neck cancers. Inverse associations were observed for history of allergy and asthma with oropharyngeal and laryngeal cancers, but not with oral cancer. The findings for allergies were similar after stratifying by sex, smoking status, or HPV16 serostatus, suggesting that the association with allergy is independent of these known risk factors.
In a large cohort study, individuals with self-reported history of both hay fever and asthma had a lower risk of overall cancer mortality compared with those who reported no history of hay fever or asthma (OR = 0.88, 95 % CI = 0.83-0.93) [22] . For cancer specific mortality, pancreatic cancer mortality was significantly lower among those with a history of hay fever (OR = 0.85, 95 % CI = 0.77-0.95) while colorectal cancer mortality was lower among those with a history of both hay fever and asthma (OR = 0.76, 95 % CI = 0.64-0.91) [22] ; the association between allergies and HNSCC mortality was not assessed. Few cohorts have sufficient data to allow for prospective examination of the relation between allergies and head and neck cancers, although some studies have reported lower risk of head and neck cancers among asthmatic patients [8, 9] .
Two previous case-control studies examined the relation between allergies and risk of head and neck cancers [6, 7] . As with our current study, results from the two previous studies were based on self-reported history of allergies. In contrast, both earlier studies were hospital-based casecontrol studies and neither included data on HPV serostatus. Inverse associations with allergies from the two prior studies on head and neck cancer were stronger than those observed in our study. However, prevalence rates for any allergies among controls were lower than expected (8.7 % [7] ; 17.5 % in men and 26.5 % in women [6] ), which may have led to biased results.
Associations between allergies and risk of head and neck cancers did not apply to oral cancers in this study population. This may be simply due to lower power in this subset, although cancers of the oral cavity comprise 60 % of our total HNSCC cases. Alternatively, it is plausible that the response is different for these tumors. Given that a history of allergy is not ubiquitously related to all cancer sites, it may also apply to head and neck cancer subsites. Potential mechanisms for the apparent protective effect of allergies on the development of certain tumors are not well understood. Research is being conducted in this field with efforts to understand pathways to develop new treatments [10] . It has been proposed that immunoglobulin E (IgE), which is elevated in individuals with allergies, may have a natural surveillance function in certain malignancies. A high number of IgE-positive cells were found in tumor tissue compared to normal hypopharyngeal mucosa, but no significant differences were observed for IgG, IgA, and IgM [23] .
The strengths of this study include a large number of cases with head and neck cancer, and detailed data on potential confounders, including smoking, alcohol, and HPV16 serostatus. Limitations include the retrospective study design and the low response rates among controls that could have introduced selection bias. However, selection bias is unlikely to explain our findings given that the prevalence of allergies among controls (40 %) is similar to the reported prevalence in NHANES data (34 % had diagnosed allergies overall age groups [24] ; as the younger age groups have lower prevalence, the prevalence would be higher for the comparable age group from this study). Finally, history of allergies and asthma was self-reported by study participants, and confirmation of these conditions was not possible. In this large population-based case-control study, we observed an inverse association between allergies and risk of HNSCC, as previously reported in two case-control studies. The association was not confounded or modified by HPV16 serostatus or smoking and appeared to be strongest among oropharyngeal and laryngeal cancers. These findings are consistent with inverse associations, which have been reported for other types of cancers, and suggest that the Th2 immune function may play a key role in carcinogenesis in HNSCC.
